Trials / Completed
CompletedNCT00209430
Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography
GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 408 (planned)
- Sponsor
- GE Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate and compare the effects on kidney function of two contrast media, the iso-osmolar iodixanol and the low-osmolar iopamidol in patients at risk of kidney damage associated with the injection of contrast media. A standard hydration procedure, based on available guidelines will be given to all patients to prevent negative effects on the kidneys. Serum creatinine (SCr ) concentrations will be measured before and up to 7 days after contrast media administration to evaluate the effects on renal function.
Detailed description
GEHC has decided not to provide this detail
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iodixanol 320 mgI/mL |
Timeline
- Start date
- 2005-08-01
- First posted
- 2005-09-21
- Last updated
- 2007-10-31
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00209430. Inclusion in this directory is not an endorsement.